MedPath

A dietary study investigating the beneficial effects of a traditional Mediterranean diet on weight, diabetes control and heart disease risk in people with Type 2 diabetes.

Completed
Conditions
Type 2 diabetes
Metabolic and Endocrine - Diabetes
Registration Number
ACTRN12607000394448
Lead Sponsor
ational Health and Medical Research Council (NHMRC)
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
25
Inclusion Criteria

Type 2 diabetes, Australian-born.

Exclusion Criteria

Presence of disabling stroke, cancer not in remission, renal failure, or liver disease; an inability to attend the three hour interview session and participate in the examinations due to incapacitation; or inability to complete the three month dietary intervention due to medical, cultural or religious factors.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Consumption of the intervention diet resulted in a small but significant improvement in glycaemic control (HbA1c fell from 7.1% to 6.8%; p=0.012) and a trend towards weight loss despite a reported 25% higher energy intake.<br>Primary Outcome: Glycaemic control[Timepoints: at baseline, week 12 and week 24.];Primary Outcome: weight loss[Timepoints: at baseline, week 12 and week 24.];Primary Outcome: Lipids[Timepoints: at baseline, week 12 and week 24.];Primary Outcome: blood pressure[Timepoints: at baseline, week 12 and week 24.]
Secondary Outcome Measures
NameTimeMethod
Consumption of the intervention diet resulted in significant improvements in diet quality; plant to animal food ratio increased from 1.3-5.4; plasma lycopene and lutein/zeaxanthin increased (36% and 25%, respectively) consistent with adherence to the intervention diet supplied: higher intakes of leafy vegetables, tomatoes, garlic and olive oil.<br>Secondary Outcomes: Plasma carotenoids.[At baseline, week 12 and week 24.];Secondary Outcomes: Dietary plant to animal food ratio.<br>[At baseline, week 12 and week 24.]
© Copyright 2025. All Rights Reserved by MedPath